A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
AbbVie
Jazz Pharmaceuticals
Pfizer
AstraZeneca
Eli Lilly and Company
UMC Utrecht
ViroMissile, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Arvinas Inc.
Tasca Therapeutics
MacroGenics
Daiichi Sankyo
University of Nebraska
Zhejiang University
Adela, Inc
Natera, Inc.
Var2 Pharmaceuticals
VM Oncology, LLC
Degron Therapeutics Co.
Cancer Research UK
Massive Bio, Inc.
Maastricht University Medical Center
LigaChem Biosciences, Inc.
GI Innovation, Inc.
Memgen, Inc.
Bicara Therapeutics
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Nanjing First Hospital, Nanjing Medical University
Nanjing First Hospital, Nanjing Medical University
University Health Network, Toronto
ImmunoGenesis
European Organisation for Research and Treatment of Cancer - EORTC
Cancer Research UK
Zhejiang Provincial People's Hospital
Zhujiang Hospital
University of Sydney
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Hospices Civils de Lyon